Cervical Cancer Screening Positivity Among Women Living With HIV in CDC-PEPFAR Programs 2018-2022

被引:1
作者
Mccormick, Laura J. [1 ,18 ]
Gutreuter, Steve [1 ]
Adeoye, Oluwatosin [2 ]
Alger, Sarah X. [3 ]
Amado, Celeste [4 ]
Bay, Zurnaid [5 ]
Chirwa, Catherine Motswere [6 ]
Chituwo, Omega [7 ]
Correia, Della [5 ]
Deus, Maria [5 ]
Dirlikov, Emilio [3 ]
Efuntoye, Tim [2 ]
Gunde, Laurence [8 ]
Kabaghe, Alinune [8 ]
Kalamya, Julius N. [3 ]
Lorenzoni, Cesaltina [4 ]
Magesa, Daniel [9 ]
Mate, Celina [4 ]
Mulokoshi, Theopolina [10 ]
Ninsiima, Josephine Connie [11 ]
Nyangasi, Mary [12 ]
Nyika, Ponesai [13 ]
Pasipamire, Munyaradzi [14 ]
Ssali, Mina [15 ]
Tefera, Fana [16 ]
Torre, Lindsey A. [1 ]
Urso, Marilena [5 ]
Wandira, Ronald [6 ]
Zemburuka, Brigitte [17 ]
Montandon, Michele [1 ]
机构
[1] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA USA
[2] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Abuja, Nigeria
[3] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Kampala, Uganda
[4] Minist Hlth, Natl Cerv Canc Control Program, Maputo, Mozambique
[5] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Maputo, Mozambique
[6] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Gaborone, Botswana
[7] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Lusaka, Zambia
[8] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Lilongwe, Malawi
[9] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Dar Es Salaam, Tanzania
[10] Minist Hlth & Social Serv, Windhoek, Namibia
[11] Makerere Univ, Sch Publ Hlth, Kampala, Uganda
[12] Minist Hlth, Div Natl Canc Control Program, Nairobi, Kenya
[13] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Harare, Zimbabwe
[14] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Mbabane, Eswatini
[15] Minist Hlth, Off Director Publ Hlth, Kampala, Uganda
[16] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Addis Ababa, Ethiopia
[17] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Windhoek, Namibia
[18] Ctr Global Hlth Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA
关键词
cervical cancer; screening; HIV; HPV; HUMAN-PAPILLOMAVIRUS; LESIONS; RISK;
D O I
10.1097/QAI.0000000000003286
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Supplemental Digital Content is Available in the Text. Background:The US President's Emergency Plan for AIDS Relief aims to address the higher risk of cervical cancer among women living with HIV by offering high-quality screening services in the highest burden regions of the world.Methods:We analyzed the US President's Emergency Plan for AIDS Relief Monitoring, Evaluation, and Reporting data from Centers for Disease Control and Prevention-supported sites in 13 countries in sub-Saharan Africa for women living with HIV aged older than 15 years who accessed cervical cancer screening services (mostly visual inspection, with ablative or excisional treatment offered for precancerous lesions), April 2018-March 2022. We calculated the positivity by age, country, and clinical visit type (first lifetime screen or routine rescreening). We fitted negative binomial random coefficient models of log-linear trends in time to estimate the probabilities of testing positive and any temporal trends in positivity.Results:Among the 2.8 million completed cancer screens, 5.4% identified precancerous lesions, and 0.8% were positive for suspected invasive cervical cancers (6.1% overall). The positivity rates declined over the study period among those women screening for cervical cancer for the first time and among those women presenting to antiretroviral therapy clinics for routine rescreening.Conclusions:These positivity rates are lower than expectations set by the published literature. Further research is needed to determine whether these lower rates are attributable to the high level of consistent antiretroviral therapy use among these populations, and systematic program monitoring and quality assurance activities are essential to ensure women living with HIV have access to the highest possible quality prevention services.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 2004, PLANNING IMPLEMENTIN
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Stan: A Probabilistic Programming Language [J].
Carpenter, Bob ;
Gelman, Andrew ;
Hoffman, Matthew D. ;
Lee, Daniel ;
Goodrich, Ben ;
Betancourt, Michael ;
Brubaker, Marcus A. ;
Guo, Jiqiang ;
Li, Peter ;
Riddell, Allen .
JOURNAL OF STATISTICAL SOFTWARE, 2017, 76 (01) :1-29
[4]   Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening [J].
Castle, P. E. ;
Qiao, Y-L ;
Zhao, F-H ;
Chen, W. ;
Valdez, M. ;
Zhang, X. ;
Kang, L-N ;
Bansil, P. ;
Paul, P. ;
Bai, P. ;
Peck, R. ;
Li, J. ;
Chen, F. ;
Jeronimo, J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 (06) :739-746
[5]  
Ferlay J, 2010, BREAST CANCER EPIDEMIOLOGY, P1, DOI 10.1007/978-1-4419-0685-4_1
[6]  
George W., 2021, Go Further Fact Sheets
[7]   Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership [J].
Godfrey, Catherine ;
Prainito, Amber ;
Lapidos-Salaiz, Ilana ;
Barnhart, Matthew ;
Watts, D. Heather .
PREVENTIVE MEDICINE, 2021, 144
[8]  
Goodrich B., 2022, RSTANARM BAYESIAN AP
[9]   The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV [J].
Gopalappa, Chaitra ;
Stover, John ;
Shaffer, Nathan ;
Mahy, Mary .
AIDS, 2014, 28 :S5-S14
[10]  
International Agency for Research on Cancer (IARC), 2022, Cervical Cancer Screening. IARC Handbook of Cancer Prevention, VVol 18, P1